Mahmud Ehtisham, Pourdjabbar Ali, Ang Lawrence, Behnamfar Omid, Patel Mitul P, Reeves Ryan R
Division of Cardiovascular Medicine, University of California, San Diego Sulpizio Cardiovascular Center, La Jolla, California.
Catheter Cardiovasc Interv. 2017 Nov 15;90(6):956-962. doi: 10.1002/ccd.27209. Epub 2017 Aug 10.
Robotic technology has been utilized in cardiovascular medicine for over a decade, and over that period, its use has been expanded to percutaneous coronary and peripheral vascular interventions. The safety and feasibility of robotically assisted percutaneous cardiovascular interventions has been demonstrated in studies including simple to complex coronary lesions, and both iliac and femoropopliteal lesions. These reports have shown that robotically assisted PCI significantly reduces operator exposure to harmful ionizing radiation without a detrimental effect on procedural success or clinical efficacy. Additionally, the use of robotics has the intuitive benefit of alleviating the risk of orthopedic injuries faced by interventional operators. In addition to the interventional operator benefits, robotically assisted intervention has the potential for patient level benefit by allowing more accurate lesion length measurement, precise stent placement, and lower patient radiation exposure. However, further investigation is required to fully elucidate these potential benefits.
机器人技术在心血管医学领域的应用已有十多年，在此期间，其应用范围已扩展到经皮冠状动脉和外周血管介入治疗。包括简单至复杂冠状动脉病变以及髂动脉和股腘动脉病变在内的研究已证明机器人辅助经皮心血管介入治疗的安全性和可行性。这些报告表明，机器人辅助的经皮冠状动脉介入治疗（PCI）显著减少了术者暴露于有害电离辐射的剂量，且对手术成功率或临床疗效没有不利影响。此外，机器人技术的使用具有直观的好处，即减轻了介入手术者面临的骨科损伤风险。除了对介入手术者有益外，机器人辅助介入治疗还可能给患者带来好处，比如能够更精确地测量病变长度、精准放置支架以及减少患者的辐射暴露。然而，需要进一步研究以充分阐明这些潜在益处。
